Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE from Antwerpen, company number BE0817283495, closed financial year 2025 with a result of € -35,508 after tax. For that financial year DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE recorded a gross margin of € -250 and equity of € 292,427. Compared with financial year 2024, the result moved from € 19,867 to € -35,508. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 17, 2026.
€ 292,427
▼ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -35,508
▼ still € 19,867 profit in 2024
Profit after tax over the fiscal year.
€ 0
▼ 100% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 280,027.
People and assets in 2025
€ 6,680
▼ 87% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 38,376
▼ 25% vs 2024
€ 4,551 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 8,871
▼ 39% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,975
▼ 71% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 97,771 | € 143,509 | € 54,550 | € -250 | ▼ € 54,800 |
| Profit after taxes | € 54,362 | € 81,975 | € 19,867 | € -35,508 | ▼ € 55,375 |
| Equity | € 226,094 | € 111,882 | € 327,935 | € 292,427 | ▼ 11% |
| Total debts | € 73,449 | € 324,619 | € 134,383 | € 67,222 | ▼ 50% |
| Cash | € 111,330 | € 163,386 | € 148,305 | € 0 | ▼ 100% |
| Retained profit | € 213,694 | € 99,482 | € 315,535 | € 280,027 | ▼ 11% |
| Bank debt | € 30,573 | € 262,482 | € 51,060 | € 38,376 | ▼ 25% |
| Balance sheet total | € 299,544 | € 436,501 | € 462,318 | € 359,649 | ▼ 22% |
Key figures of DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE?
What happened at DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 35,508 (▼ € 55,375 vs 2024). filed late Source: NBB ↗
- Cathérine Lannoy became a director. NBB
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
In short
From € 54,362 profit in 2022 to € 35,508 loss in 2025.
Paid € 74,382 in corporate taxes since 2022.
Best year ever: 2023, with € 81,975 profit.
A new publication or filing at DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE? We notify you, reason included.
Follow DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE is Cathérine Lannoy.
Directors
According to the 2025 annual accounts
Cathérine Lannoy
Bewindvoerder
since 2025
Establishments
Establishment units
Physical locations of this company
Brusselstraat 51
2018 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0817.283.495
- VAT number
- BE 0817.283.495
- Registered office
- Brusselstraat 51, 2018 Antwerpen
- Names & denominations
- DR. S. PRIVALENKO, ALGEMENE EN ACUTE GENEESKUNDE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 July 2009
- Peppol
- Not registered